QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.106.112532v1 320/1/475    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wainscott, D. B. Articles by Nelson, D. L. Search for Related Content PubMed PubMed Citation Articles by Wainscott, D. B. Articles by Nelson, D. L.

NEUROPHARMACOLOGY

Pharmacologic Characterization of the Cloned Human Trace Amine-Associated Receptor1 (TAAR1) and Evidence for Species Differences with the Rat TAAR1

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana

The hemagglutinin-tagged human trace amine-associated receptor1 (TAAR1) was stably coexpressed with rat G_s in the AV12-664 cell line, and receptor activation was measured as the stimulation of cAMP formation. After blockade of endogenously expressed ₂- and -adrenoceptors with 2-[2-(2-methoxy-1,4-benzodioxanyl)]-imidazoline hydrochloride (2-methoxyidazoxan, RX821002) and alprenolol, respectively, the resulting pharmacology was consistent with that of a unique receptor subtype. -Phenylethylamine (-PEA), the putative endogenous ligand, gave an EC₅₀ of 106 ± 5 nM in the assay. For a series of -PEA analogs used to explore the pharmacophore, small substituents at ring positions 3 and/or 4 generally resulted in compounds having lower potency than -PEA, although several were as potent as -PEA. However, small substituents at ring position 2 resulted in a number of compounds having potencies as good as or better than -PEA. A number of nonselective antagonists known to share affinity for multiple monoaminergic receptors were evaluated for their ability to inhibit -PEA stimulation of the human TAAR1. None had an IC₅₀ <10 µM. For comparison, the rat TAAR1 receptor was expressed in the AV12-664 cell line. A number of agonist compounds had significantly different relative potencies between the rat and human TAAR1, demonstrating a significant species difference between the rat and human TAAR1. The TAAR1 receptor exhibits a pharmacologic profile uniquely different from those of classic monoaminergic receptors, consistent with the structural information that places them in a distinct family of receptors. This unique pharmacologic profile suggests the potential for development of TAAR-selective agonists and antagonists to study their physiologic roles.

Address correspondence to: David B. Wainscott, Eli Lilly and Company, Lilly Corporate Center, Mail Drop 0510, Indianapolis, IN 46285. E-mail: dbwainscott{at}lilly.com

This article has been cited by other articles:

				L. S. Barak, A. Salahpour, X. Zhang, B. Masri, T. D. Sotnikova, A. J. Ramsey, J. D. Violin, R. J. Lefkowitz, M. G. Caron, and R. R. Gainetdinov Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP Biosensor Mol. Pharmacol., September 1, 2008; 74(3): 585 - 594. [Abstract] [Full Text] [PDF]

				E. A. Reese, J. R. Bunzow, S. Arttamangkul, M. S. Sonders, and D. K. Grandy Trace Amine-Associated Receptor 1 Displays Species-Dependent Stereoselectivity for Isomers of Methamphetamine, Amphetamine, and Para-Hydroxyamphetamine J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 178 - 186. [Abstract] [Full Text] [PDF]

				Z. Xie, S. V. Westmoreland, M. E. Bahn, G.-L. Chen, H. Yang, E. J. Vallender, W.-D. Yao, B. K. Madras, and G. M. Miller Rhesus Monkey Trace Amine-Associated Receptor 1 Signaling: Enhancement by Monoamine Transporters and Attenuation by the D2 Autoreceptor in Vitro J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 116 - 127. [Abstract] [Full Text] [PDF]

				Z. Xie and G. M. Miller Trace Amine-Associated Receptor 1 Is a Modulator of the Dopamine Transporter J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 128 - 136. [Abstract] [Full Text] [PDF]